HOME > TOP STORIES

TOP STORIES

BUSINESS Ajinomoto to Acquire US Contract Biologic Manufacturer Althea

March 7, 2013
REGULATORY MHLW Approves 45 New Compounds in 2012: Mr Akagawa of PFSB

March 6, 2013
BUSINESS 2 SGLT-2 Inhibitors to Be Filed for Approval without Concurrent-Use Restrictions

March 5, 2013
BUSINESS Pfizer Positive about In-Licensing Other Firms’ Long-Listed Drugs: VP Matsumori

March 5, 2013
REGULATORY Lawmakers Organizing Non-Partisan Group to Break Deadlock on Establishment of 3rd-Party Drug Administration Watchdog Organization

March 5, 2013
BUSINESS Pfizer Japan’s Ethical Drug Sales Dip 4.2% on Lipitor Patent Expiry: FY2012 Earnings

March 4, 2013
BUSINESS ARB Sales Apparently Peak Out in Japan Antihypertensive Market

March 1, 2013
REGULATORY 5 Years Too Long to Achieve Reference Generic Share Target of 60%: Bill Payer Reps at CSIMC Subcommittee

February 28, 2013
ORGANIZATION Relationships with Doctors Unchanged after Stricter Rules on Entertainment: Maker FTC Survey

February 27, 2013
REGULATORY JMACCT Revamps Database of Clinical Trial Institutions; Details Now Available Online

February 27, 2013
BUSINESS Takeda Recalling Renal Anemia Drug Omontys in US after Death Reports

February 26, 2013
ORGANIZATION TPP Hoped to Set Standard for Global IP Protection Rules: PhRMA Japan Rep. Wolf

February 25, 2013
BUSINESS LEO Pharma of Denmark to Fully Enter Psoriasis Market in Japan in 2014

February 22, 2013
ORGANIZATION JPMA’s New Code of Practice to Take Effect in April; Transparency in Relations with Wholesalers to Be One Focus

February 22, 2013
ORGANIZATION Osaka-Based NPO to Take on Outsourcing of GMP Compliance Audit on Drug Substance Makers

February 21, 2013
BUSINESS DSP Targets Sales of 450 Billion Yen in FY2017 by Making Latuda Blockbuster

February 19, 2013
BUSINESS Kowa Says Listing Application for Livalo Generic “Won’t Be Filed”; Possibility Nixed for 1st AG in Japan

February 18, 2013
BUSINESS Daiichi Sankyo to Launch New Firm for Duchenne Muscular Dystrophy Therapy Jointly with Govt-Backed Fund

February 15, 2013
BUSINESS AZ Takes Over GLP-1 Receptor Agonist Bydureon from Eli Lilly in Japan

February 14, 2013
BUSINESS Novartis Sales Up 2.5% in 2012 Thanks to Rapid Growth in New Fields

February 13, 2013

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

MHLW Floats Deducting Private-Practice Use for Re-Pricing, but Off-Cycle Cuts Possible; GLP-1 Eyed?

Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…